共 25 条
[2]
Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil[J]. José Miguel Luz Parente,Claudio Saddy Rodrigues Coy,Viriato Campelo,Mírian Perpétua Palha Dias Parente,Leonardo Araújo Costa,Renata Mendes da Silva,Celso Stephan,José Murilo Robilotta Zeitune.World Journal of Gastroenterology. 2015(04)
[4]
Inflammatory Bowel Disease in Latin America: A Systematic Review[J] . María Calderón,Nicole Minckas,Solange Nu?ez,Agustín Ciapponi.Value in Health Regional Issues . 2018
[5]
Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy[J] . Rogério S. Parra,Marley R. Feitosa,Letícia C. H. Ribeiro,Lais A. Castro,José J. R. Rocha,Omar Féres,Paolo Gionchetti.Gastroenterology Research and Practice . 2018
[6]
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J] . Siew C Ng,Hai Yun Shi,Nima Hamidi,Fox E Underwood,Whitney Tang,Eric I Benchimol,Remo Panaccione,Subrata Ghosh,Justin C Y Wu,Francis K L Chan,Joseph J Y Sung,Gilaad G Kaplan.The Lancet . 2017 (1011)
[7]
Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014[J] . Caroline B?hler,Stephan R. Vavricka,Alain M. Schoepfer,Beat Brüngger,Oliver Reich.BMC Gastroenterology . 2017 (1)
[8]
Drug resistance in inflammatory bowel diseases[J] . Jacques Moreau,Emmanuel Mas.Current Opinion in Pharmacology . 2015
[9]
Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease[J] . Nicolas Williet,William J. Sandborn,Laurent Peyrin–Biroulet.Clinical Gastroenterology and Hepatology . 2014
[10]
Determinants of health-related quality of life in Crohn’s disease: A systematic review and meta-analysis[J] . Mike van der Have,Karen S. van der Aalst,Ad A. Kaptein,Max Leenders,Peter D. Siersema,Bas Oldenburg,Herma H. Fidder.Journal of Crohn’s and Colitis . 2014 (2)